Skip to content

Effects of Graft Vascular Dimensions on Surgical and Functional Outcomes of Living Donor Kidney Transplantation

Effects of Graft Vascular Dimensions on Perioperative Surgical and Functional Outcomes of Living Donor Kidney Transplantation in Pediatrics and Adults: A Prospective Case Series

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05797389
Enrollment
30
Registered
2023-04-04
Start date
2023-04-30
Completion date
2025-04-30
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Kidney Transplant; Complications

Keywords

kidney transplantation, renal transplantation, vascular dimensions, vascular parameters

Brief summary

1. Correlate the radiological and intraoperative measuring of the vascular dimensions, 2. Assess the effect of the vascular dimensions on the short-term surgical complications and 3. Assess the effect of the vascular dimensions on the primary graft function in pediatric and adults KTs.

Detailed description

Vascular complications after kidney transplantation (KT) are variably rare with an incidence of 3-15%. They are a significant and most serious part of surgical complications of KT. They may acutely result in graft loss during surgery or early in the perioperative period and may threaten patient's life. The most common forms of early vascular complications are haemorrhage, hematomas, arterial or venous thrombosis, arterial vasospasm, and arterial intimal dissection. In pediatric and adult KT, most studies addressing the vascular complications followed a common attitude of estimating the prevalence and management of these complications rather than studying the predisposing factors. Specifically, studying the normal and abnormal anatomy of the grafts has mainly been directed towards the number of graft vessels. However, there are many other vascular parameters that may potentially influence the outcome of vascular anastomosis and therefore the graft and patient outcomes. To the best of the investigators knowledge, the vascular dimensions of the renal and iliac vessels, such as the length, diameter and site of anastomosis to the iliac vessels have not been studied before so the investigators hypothesis that these dimensions can unequally affect the outcomes of surgery and early graft function in KTs. Hence, this study will be conducted to assess the effects of the vascular dimensions on the outcomes of surgery and primary graft function in pediatric versus adult living donor KT.

Interventions

None listed

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Pediatric and adult patients undergoing living donor kidney transplantation.

Exclusion criteria

* Patients with acute graft rejection occurring within the first week of transplantation. * Patients refusing participation in the study.

Design outcomes

Primary

MeasureTime frameDescription
Mode of graft function defined by: 1- the time of start of diuresis post-transplantation.one month post operative.Mode of graft function defined by: 1- the start of diuresis (sufficient amount of urine production) within one hour of declamping through the first week post-transplantation
2- Rate of decline of the serum creatinine level.one month post operative.2- Rate of decline of the serum creatinine level.

Secondary

MeasureTime frameDescription
The rate of other surgical complications.one month post operativeThe rate of other surgical complications.
The rate of vascular complications (intra- or perioperative).one month post operativeThe rate of vascular complications (intra- or perioperative): In the form of spasm, hemorrhage, dissection, or thrombosis.

Contacts

Primary ContactMohamed L Shehata
mohamed.l.m.sh@gmail.com00201093590017
Backup ContactRabea A Gadelkareem
dr.rabeagad@yahoo.com00201001529356

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026